NCT00416624
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +72 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Lymphoma, Large-Cell, Immunoblastic
Explore clinical trials studying Lymphoma, Large-Cell, Immunoblastic. Study availability and eligibility vary by location and protocol.
372 public trials
3 recruiting studies
Lymphoma, Large-Cell, Immunoblastic trial results
NCT00719563
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
NCT00104975
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +58 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
NCT00053053
- Conditions
- Body Weight, Body Weight Changes, Burkitt Lymphoma, +44 more
- Locations
-
- Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
- Comprehensive Cancer Institute Huntsville, Alabama, United States
- MBCCOP - Gulf Coast Mobile, Alabama, United States
- Montgomery Cancer Center Montgomery, Alabama, United States
Completed
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00005601
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
- Locations
-
- CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
- CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
NCT00047164
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +33 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
NCT00032019
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Northeast Alabama Regional Medical Center Anniston, Alabama, United States
- Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
- Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center Los Angeles, California, United States
- Naval Medical Center - San Diego San Diego, California, United States
NCT00005964
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
- University of California San Diego Cancer Center La Jolla, California, United States
- Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
- UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
NCT00003863
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
- Locations
-
- Northeast Alabama Regional Medical Center Anniston, Alabama, United States
- Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
- Naval Medical Center - San Diego San Diego, California, United States
- Veterans Affairs Medical Center - San Diego San Diego, California, United States
Completed
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
NCT00062114
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
- Moores UCSD Cancer Center La Jolla, California, United States
- Kaiser Permanente Medical Office -Vandever Medical Office San Diego, California, United States